The World Health Day theme highlighted the need to prevent the disease in the developing world, and the fact that many groups play a part
With brand new data showing that the global population with diabetes has reached 422 million, the World Health Organization’s selection is diabetes as its theme for World Health Day is well-timed. The day will focus on the need to prevent type 2 diabetes, especially in developing nations.
Meanwhile, in Geneva, Switzerland, a presentation of findings of the ACCISS study focused on the lack of availability of insulin for type 1 patients (and some with type 2 disease), more than 90 years after Canadian researchers discovered this life-saving therapy for patients who cannot produce their own.
According to the WHO, the aims of World Health Day are to:
· Build awareness of the global increase in the diabetes burden and its impact, especially in low- and middle-income countries.
· Create specific and affordable tactics to fight diabetes, with a focus on prevention.
· Launch a global report on diabetes, covering the impact of both type 1 and type 2 disease.
· Promote the fact that diabetes is preventable: work with food and beverage manufacturers, employers, educators, civic groups, the media and individuals themselves to change behavior.
Availability of Insulin
Researchers at the University of Geneva have been spreading the message about the cost of insulin for some time. A panel discussion today highlighted the fact that cost is barrier for about half the 100 million people who need insulin each day.
David Beran, a researcher at the University of Geneva’s division of tropical and humanitarian medicine, said there are companies that could supply cheaper insulin than the “big three”—Novo Nordisk, Sanofi, and Eli Lilly—including companies in India and China, where rates of diabetes are exploding. But discussions need to happen to create new, lower-cost sources of insulin. No generic formulations are available globally, the according to the University of Geneva group.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen